ESMO Shares Recommendations to Support Cancer Research and Clinical Trials in Europe By Ogkologos - May 28, 2026 172 0 Facebook Twitter Google+ Pinterest WhatsApp EU Competitiveness Council (Research) Source RELATED ARTICLESMORE FROM AUTHOR Perioperative Durvalumab Plus FLOT Improves OS in Patients with Resectable Gastric or GEJ Adenocarcinoma Advancing Childhood Cancer Research: A Conversation with Dr. Brigitte Widemann Azacitidine-Venetoclax Prolongs EFS Over Induction Chemotherapy Among Induction-Eligible Patients with AML MOST POPULAR FDA Approves Durvalumab with Chemotherapy for Mismatch Repair Deficient Primary Advanced... July 19, 2024 ASCO20 Virtual Research Round Up Podcast: Breast Cancer, Sarcoma, and Supportive... July 21, 2020 Cancer Patients Have Been Lonelier During the COVID-19 Pandemic May 27, 2021 Limited Effect of Endocrine Therapy on Distant Metastasis-Free Interval in Patients... December 13, 2021 Load more HOT NEWS Cabozantinib Plus Nivolumab and Ipilimumab Results in Longer PFS in Previously... FDA Approves Relugolix for Advanced Prostate Cancer Higher Risk of Invasive Behaviour for Oncogenic Fusions–Driven Paediatric Thyroid Cancers FDA Approves Lutetium Lu 177 Dotatate for Paediatric Patients 12 Years...
